Skip to main content
Premium Trial:

Request an Annual Quote

GeneDx: Michael Pellini

Michael Pellini has resigned from the board of GeneDx. According to a regulatory filing, Pellini wants to devote more of his time to venture capital firm Section 32, where he is a managing partner. GeneDx said that the resignation "did not result from any disagreements" with the company or any other board members. Pellini is a former chairman and CEO of Foundation Medicine.